9th Bay Area life science IPO of year raises more than expected

Allakos Inc. raised $127.8 million in an upsized IPO on Thursday that priced above its target range. The San Carlos developer of antibody therapeutics for allergic and inflammatory diseases sold 7.1 million shares at $18 each and is poised to begin trading on Nasdag exchange with the symbol of "ALLK." It was expected to sell 6 million shares for between $15 and $17 each, with insiders buying a bout $35 million in shares — accounting for 27 percent of the deal. The offering is the ninth of the…
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Source Type: news